<?xml version="1.0" encoding="UTF-8"?>
<p>HIV testing is a major gap in the treatment cascade worldwide and the main obstacle to treatment in many low- to middle-income countries (LMICs) [
 <xref rid="pone.0234697.ref001" ref-type="bibr">1</xref>], including Indonesia where in 2019 only half (51%) of the estimated 640,000 people living with HIV (PLHIV) were diagnosed [
 <xref rid="pone.0234697.ref002" ref-type="bibr">2</xref>]. To increase diagnosis, HIV testing should target populations with the highest HIV incidence. Two important populations for HIV testing are people in prison, who are disproportionately affected by HIV [
 <xref rid="pone.0234697.ref003" ref-type="bibr">3</xref>], and their sex and drug-injecting partners in the community, who also are at risk [
 <xref rid="pone.0234697.ref004" ref-type="bibr">4</xref>â€“
 <xref rid="pone.0234697.ref006" ref-type="bibr">6</xref>]. An estimated 389,000 PLHIV are incarcerated worldwide at any given time and many more transition through jails and prisons each year [
 <xref rid="pone.0234697.ref003" ref-type="bibr">3</xref>]. Although many PLHIV are diagnosed in prison, their sex and drug-injecting partners in the community may be missed for HIV testing and treatment [
 <xref rid="pone.0234697.ref004" ref-type="bibr">4</xref>].
</p>
